Caplin Point Laboratories マネジメント
マネジメント 基準チェック /44
Caplin Point Laboratories' CEO is Sridhar Ganesan, appointed in Mar 2015, has a tenure of 9.67 years. total yearly compensation is ₹9.30M, comprised of 95.7% salary and 4.3% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth ₹194.13M. The average tenure of the management team and the board of directors is 8.8 years and 4.7 years respectively.
主要情報
Sridhar Ganesan
最高経営責任者
₹9.3m
報酬総額
| CEO給与比率 | 95.7% |
| CEO在任期間 | 9.7yrs |
| CEOの所有権 | 0.1% |
| 経営陣の平均在職期間 | 8.8yrs |
| 取締役会の平均在任期間 | 4.7yrs |
経営陣の近況
Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15
We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Recent updates
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 31Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50
Sep 12Earnings Update: Here's Why Analysts Just Lifted Their Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Price Target To ₹1,764
Aug 11Caplin Point Laboratories (NSE:CAPLIPOINT) Is Paying Out A Dividend Of ₹2.50
Aug 10Investors Aren't Buying Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Earnings
Jul 12Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues
May 24Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?
May 04Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement
Mar 07With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 24Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50
Aug 11We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 11Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?
Jul 22Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00
May 15A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Jan 21Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?
Oct 20Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50
Sep 17Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50
Sep 03Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price
Aug 27Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?
Jun 12Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Apr 29Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?
Mar 24CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹5b |
| Mar 31 2024 | ₹9m | ₹9m | ₹5b |
| Dec 31 2023 | n/a | n/a | ₹4b |
| Sep 30 2023 | n/a | n/a | ₹4b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹9m | ₹8m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹6m | ₹5m | ₹3b |
| Dec 31 2021 | n/a | n/a | ₹3b |
| Sep 30 2021 | n/a | n/a | ₹3b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹6m | ₹5m | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Sep 30 2020 | n/a | n/a | ₹2b |
| Jun 30 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹6m | ₹6m | ₹2b |
| Dec 31 2019 | n/a | n/a | ₹2b |
| Sep 30 2019 | n/a | n/a | ₹2b |
| Jun 30 2019 | n/a | n/a | ₹2b |
| Mar 31 2019 | ₹6m | ₹6m | ₹2b |
| Dec 31 2018 | n/a | n/a | ₹2b |
| Sep 30 2018 | n/a | n/a | ₹2b |
| Jun 30 2018 | n/a | n/a | ₹1b |
| Mar 31 2018 | ₹6m | ₹6m | ₹1b |
報酬と市場: Sridhar's total compensation ($USD110.59K) is below average for companies of similar size in the Indian market ($USD471.41K).
報酬と収益: Sridhar's compensation has been consistent with company performance over the past year.
CEO（最高経営責任者
Sridhar Ganesan (69 yo)
9.7yrs
在職期間
₹9,300,000
報酬
Dr. Sridhar Ganesan has been the Managing Director of Caplin Point Laboratories Ltd since March 28, 2015. Dr. Ganesan has been Whole Time Director of Caplin Point Laboratories Ltd since August 25, 2014. He...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Whole Time Director | 9.7yrs | ₹9.30m | 0.13% ₹ 194.1m | |
| Chief Financial Officer | 8.8yrs | ₹9.10m | 0.020% ₹ 29.9m | |
| Chief Operating Officer | 13.3yrs | ₹1.90m | 11.84% ₹ 17.7b | |
| General Counsel | 2.3yrs | ₹6.50m | データなし | |
| Deputy Chief Financial Officer | no data | データなし | データなし | |
| Head of Marketing - Latam Business | no data | データなし | 11.91% ₹ 17.8b | |
| Chief Transformation & Digital Officer | less than a year | データなし | データなし |
8.8yrs
平均在職期間
経験豊富な経営陣: CAPLIPOINT's management team is seasoned and experienced (8.8 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Whole Time Director | 10.8yrs | ₹9.30m | 0.13% ₹ 194.1m | |
| Non-Executive Non-Independent Chairman | 34.6yrs | データなし | 18.64% ₹ 27.9b | |
| Non-Executive Independent Director | 8yrs | ₹160.00k | データなし | |
| Non-Executive Independent Director | 4.7yrs | ₹140.00k | データなし | |
| Non-Executive Independent Director | 2.2yrs | ₹160.00k | データなし | |
| Independent Non-Executive Director | 2.2yrs | ₹180.00k | 0.000090% ₹ 134.5k | |
| Independent Director | less than a year | データなし | データなし |
4.7yrs
平均在職期間
72yo
平均年齢
経験豊富なボード: CAPLIPOINT's board of directors are considered experienced (4.7 years average tenure).